CD8+ T cell activation depends upon engagement of the CD8 receptor with antigens presented by MHC class I. MHC I and II complexes are mutated or downregulated in several cancers, and this is a major tumor immune evasion mechanism used by tumor cells to avoid immune destruction [71]. Here, CD8A is linked to cancer.